{"acquisitions":[],"changes":[],"country":"FR","description":"EG 427 is a Paris-based biotech developing DNA medicines on a non-replicative Herpes Simplex Virus 1 platform that delivers durable gene expression to peripheral neurons. It focuses on patients with severe localized chronic diseases of the peripheral nervous system, starting with bladder disorders. HSV-1 latency lets it deliver large payloads.","domain":"eg427.com","employees":null,"founded":2021,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":48.853495,"lng":2.348391,"location":"Paris, France","multiples":[],"name":"EG 427","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":29160000,"connectionsAmong":[],"currency":"EUR","date":"2025-02-15","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"eg427-com-2025-02-15-series-b","source":{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"eg427-com","sources":[{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"eg427.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://eg427.com"},{"fact":"description","publisher":"eg427.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://eg427.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","PHP","YouTube","Unpkg","jsDelivr","Plesk","core-js","Alpine.js"],"totalRaisedUsd":43200000,"traction":[],"updatedAt":"2026-05-02","valuations":[]}